Women with psoriatic arthritis endure longer diagnostic delays and report higher pain levels than men. Learn about sex-based ...

YESINTEK, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, and ...

Biocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting ...

The biosimilar is approved for the treatment of Crohn’s disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis ...

YESINTEK works by targeting specific proteins that contribute to inflammation, offering a new treatment option for patients ...

Being a teenager is tough enough with raging hormones and trying to figure out who you are but for radio DJ and wedding ...

VMPL New Delhi [India] 30 Homeocare International has redefined homeopathy by introducing a personalized and holistic ...

From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light ...

Discovered and characterized at The University of North Carolina at Chapel Hill, the compound showed potent PDE4D inhibition ...

Alumis is advancing ESK-001 for plaque psoriasis with phase 3 data expected in 2026. Read why ALMS stock is compelling yet ...

Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but ...

This false information surrounds the availability of FEMA relief and other disaster assistance, including tax implications. For example, FEMA personnel in North Carolina recently faced alarming ...